Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luspatercept Versus Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies
NCT07636486Phase 3Not yet recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 3 trial of luspatercept, sponsored by Nanfang Hospital, Southern Medical University. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
luspatercept
Beyond the preview
Go deeper on NCT07636486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07636486.